These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12555286)

  • 21. The 14-3-3 cancer connection.
    Hermeking H
    Nat Rev Cancer; 2003 Dec; 3(12):931-43. PubMed ID: 14737123
    [No Abstract]   [Full Text] [Related]  

  • 22. Killing tumours by ceramide-induced apoptosis: a critique of available drugs.
    Radin NS
    Biochem J; 2003 Apr; 371(Pt 2):243-56. PubMed ID: 12558497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dilemma of the strive for apoptosis in oncology: mind the heart.
    Perik PJ; de Vries EG; Gietema JA; van der Graaf WT; Sleijfer DT; Suurmeijer AJ; van Veldhuisen DJ
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):101-13. PubMed ID: 15661561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRC as a potential therapeutic target in solid tumor oncology.
    Gallick GE
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):435-7. PubMed ID: 16163218
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting the Bcl-2 family in cancer therapy.
    Papadopoulos K
    Semin Oncol; 2006 Aug; 33(4):449-56. PubMed ID: 16890799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibody therapy in hematology and oncology--2].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy control in oncology by circulating nucleosomes.
    Holdenrieder S; Stieber P
    Ann N Y Acad Sci; 2004 Jun; 1022():211-6. PubMed ID: 15251962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modeling and simulation framework to support early clinical drug development decisions in oncology.
    Bruno R; Lu JF; Sun YN; Claret L
    J Clin Pharmacol; 2011 Jan; 51(1):6-8. PubMed ID: 20628172
    [No Abstract]   [Full Text] [Related]  

  • 29. A new generation of mouse models of cancer for translational research.
    Abate-Shen C
    Clin Cancer Res; 2006 Sep; 12(18):5274-6. PubMed ID: 17000659
    [No Abstract]   [Full Text] [Related]  

  • 30. p38 MAP kinase: a convergence point in cancer therapy.
    Olson JM; Hallahan AR
    Trends Mol Med; 2004 Mar; 10(3):125-9. PubMed ID: 15102355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using biomarkers in drug development.
    Workman P
    Clin Adv Hematol Oncol; 2006 Oct; 4(10):736-9. PubMed ID: 17099630
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnostics in cancer drug development.
    Sikora K
    Expert Rev Mol Diagn; 2004 Mar; 4(2):127-9. PubMed ID: 14995899
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing patterns of surgical oncologists: are we surgeons, oncologists, or both? Results of a society of surgical oncology survey.
    Balch CM
    Ann Surg Oncol; 2007 Oct; 14(10):2685-6. PubMed ID: 17786520
    [No Abstract]   [Full Text] [Related]  

  • 35. Antisense technologies targeting fatty acid synthetic enzymes.
    Lin J; Liu F; Jiang Y
    Recent Pat Anticancer Drug Discov; 2012 May; 7(2):198-206. PubMed ID: 22339357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
    Kostanová-Poliaková D; Sabová L
    Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness.
    Conklin KA
    Integr Cancer Ther; 2004 Dec; 3(4):294-300. PubMed ID: 15523100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 family members as molecular targets in cancer therapy.
    Marzo I; Naval J
    Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targets for treatment success.
    Simon R
    Nat Clin Pract Oncol; 2006 Jan; 3(1):1. PubMed ID: 16407857
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.
    Kim R; Emi M; Tanabe K; Uchida Y; Arihiro K
    Eur J Surg Oncol; 2006 Apr; 32(3):269-77. PubMed ID: 16431074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.